Form 8-K - Current report:
SEC Accession No. 0001607062-24-000161
Filing Date
2024-05-08
Accepted
2024-05-08 14:09:06
Documents
16
Period of Report
2024-05-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybleu050824form8k.htm   iXBRL 8-K 28585
2 EXHIBIT 16.1 ex16_1.htm EX-16.1 2391
3 GRAPHIC image_001.gif GRAPHIC 7626
4 GRAPHIC image_001.jpg GRAPHIC 3462
  Complete submission text file 0001607062-24-000161.txt   215404

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sybleu-20240506.xsd EX-101.SCH 3215
6 XBRL LABEL FILE sybleu-20240506_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE sybleu-20240506_pre.xml EX-101.PRE 22349
19 EXTRACTED XBRL INSTANCE DOCUMENT sybleu050824form8k_htm.xml XML 3540
Mailing Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465
Business Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465 718-795-7790
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-248059 | Film No.: 24925276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)